Durham, NC – February 5, 2021 – 410 Medical, Inc. a medical device company developing innovative products for resuscitation of critically ill patients, announced today that it has received Frost & Sullivan’s 2021 Entrepreneurial Company of the Year Award for Global Fluid Resuscitation Devices Industry. The award process involves a thorough evaluation of best practices across a spectrum of innovation and customer value criteria for each nominated company. Frost & Sullivan found that 410 Medical and its LifeFlow® product line excels in many of these benchmarks in the fluid resuscitation devices space.
“By enabling early fluid resuscitation and sepsis care bundle compliance, LifeFlow potentially reduces patients’ intensive care unit (ICU) admissions, ICU stay days, and 30-day readmissions, significantly lowering care costs per patient,” said Supriya Lala, Best Practices Research Analyst at Frost & Sullivan. “Simultaneously, the device-enabled early bolus of fluid infusion steadies collapsing patients and potentially saves their lives. LifeFlow’s ability to realize healthcare economics and improve clinical outcomes at the same time warrants its high economic value proposition.”
410 Medical develops novel products that enable frontline medical providers to improve care for critically ill patients. Their first product, LifeFlow, is designed to enhance the speed and efficiency of fluid resuscitation, improving care for patients with life-threatening illnesses such as sepsis and shock. The Company is currently launching the LifeFlow PLUS Blood & Fluid Infuser, providing similar benefits of fast and efficient delivery in an easy-to-use system with the added ability to deliver blood products.
“We are honored to be recognized by Frost & Sullivan as an innovator and market disrupter,” said Kyle Chenet, President and CEO of 410 Medical. “We believe now more than ever that emergency medicine and critical care providers need tools to rapidly and safely stabilize, assess and treat a crashing patient in a variety of environments. LifeFlow was designed to allow a provider in the field, in transport, or in the hospital to quickly assess volume responsiveness and restore perfusion in patients with shock and hypotension, potentially transforming resuscitation and care for these patients.”
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success.
About 410 Medical, Inc.
Founded in 2013, 410 Medical is developing and distributing innovative products that enable frontline medical providers to improve care for critically ill patients. 410 Medical’s first product family, the LifeFlow infusion system, is designed for patients in urgent need of rapid volume resuscitation. Over 50 hospitals and EMS systems are using LifeFlow in the United States. For more information visit www.410medical.com.